Newsroom

Learn more about us in our featured news stories and insights into our work

News Press Releases Locus Insights

August 29, 2018

6 CRISPR Applications from Healthcare Startups : Nanalyze

Learn More
August 21, 2018

Development of Non-Traditional Therapies for Bacterial Infections, FDA White Oak Campus

Learn More
August 1, 2018

New CRISPR Startups Get a Leg Up : GEN

Learn More
July 17, 2018

Locus Biosciences acquires EpiBiome’s high-throughput discovery platform to enhance its global leadership in CRISPR-engineered phage therapeutics

Learn More
July 8, 2018

Duke-Margolis: Emerging Non-Traditional Antibiotics

Learn More
January 3, 2018

Locus Biosciences and IDbyDNA Partner to Develop Companion Diagnostic Test for Pseudomonas aeruginosa Infection

Learn More
November 14, 2017

Locus Biosciences Closes $19 Million Series A Led by ARTIS Ventures for CRISPR-Cas3 Antimicrobials

Learn More
September 1, 2017

Cutting Through Resistance – How Locus Biosciences is Using CRISPR-Cas3 to Tackle Antibiotic Resistance : BioCentury

Learn More
July 12, 2017

Locus CEO talks Tencent investment, FDA plans : Triangle Business Journal

Learn More
July 10, 2017

Locus Biosciences Secures $5m Convertible Note for CRISPR-Cas3 Antimicrobials : PR Newswire

Learn More